Browsing Tag
Alan Taylor
1 post
Clarity Pharmaceuticals begins Phase II SECuRE trial with first patient dosed using 67Cu-SAR-bisPSMA and enzalutamide
Clarity Pharmaceuticals starts Phase II of SECuRE trial for prostate cancer, combining 67Cu-SAR-bisPSMA with enzalutamide in first treated patient.